Zdrowie i gospodarka · 01/04/2005
FDA Releases Guidance on E2E Pharmacovigilance Planning
The FDA has made available a guidance document titled 'E2E Pharmacovigilance Planning' developed under the ICH framework, outlining a method for assessing drug risks and proposing a pharmacovigilance plan for new pharmaceuticals.